Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

APEX-AMI - Pexelizumab in Conjunction With Angioplasty

NCT00091637 is registered in ClinicalTrials.gov with Procter and Gamble as lead sponsor.

NCT NCT00091637
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00091637 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
APEX-AMI - Pexelizumab in Conjunction With Angioplasty
Lead sponsor
Procter and Gamble
Phase
Phase 3
Overall status
Completed
Start date
April 30, 2004
Completion date
May 31, 2007
Enrollment
5,745 (actual)
Sites
349

Conditions

As the registry lists them; a condition with its own page is linked.

acute myocardial infarction